Edwards Lifesciences Corporatio vs Pfizer, Inc. — Stock Comparison
Edwards Lifesciences Corporatio (EW) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Edwards Lifesciences Corporatio scores ahead of Pfizer, Inc. on Q·Score (7 vs 5.7 out of 10), led by Sentiment (7.8 vs 4.9) and Health (9.2 vs 7). Pfizer, Inc. scores higher on Growth, reflecting stronger revenue and earnings momentum. Analyst consensus targets imply greater upside for EW (+10.7%) than for PFE (-4.1%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Clean balance sheet with low leverage (0.1× debt-to-equity).
⚠ earnings contracting 25% year-over-year.
Consistently beats earnings estimates (4/4 quarters).
⚠ cautious analyst consensus — few Buy ratings.
Analyst Consensus
Fundamentals
Frequently Asked Questions
EW vs PFE: which stock scores better overall?
Based on Q·Score, Edwards Lifesciences Corporatio (EW) scores 7/10 versus Pfizer, Inc. (PFE) at 5.7/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: EW or PFE?
Pfizer, Inc. (PFE) scores higher on Growth (5.9/10 vs 5.2/10). Edwards Lifesciences Corporatio reports revenue growth (13.6% YoY) while Pfizer, Inc. reports (2.6% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is EW or PFE more attractively valued?
Edwards Lifesciences Corporatio (EW) scores higher on Valuation (6.3/10 vs 5.9/10). EW trades at 27.2× P/E versus PFE at 10.6×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about EW vs PFE?
There are 27 analysts covering EW with a consensus price target of $101.87, and 26 analysts covering PFE with a consensus target of $29.26. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: EW or PFE?
Edwards Lifesciences Corporatio (EW) scores higher on Quality (6.7/10 vs 5/10). Net profit margin: EW at 15.4%, PFE at 6.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: EW or PFE?
Edwards Lifesciences Corporatio (EW) scores higher on Financial Health (9.2/10 vs 7/10). Market beta: EW at 0.86, PFE at 0.28. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of EW and PFE?
Edwards Lifesciences Corporatio (EW) has a market capitalisation of $53.0B, while Pfizer, Inc. (PFE) has a market cap of $174.0B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do EW or PFE pay dividends?
EW does not currently pay a dividend, while PFE pays a dividend yield of 5.74%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →